Full Breakdown
Sutter Health Introduces SAINT Therapy for Treatment-Resistant Depression
12/10/2025, 7:50:41 PM
Overview of SAINT Therapy
Sutter Health has launched the Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) in Sacramento, marking the first local implementation of this innovative treatment for refractory depression. Developed at Stanford University, SAINT employs MRI-guided magnetic pulses to stimulate specific areas of the brain associated with depression. This therapy is designed for adults who have not responded to at least two antidepressant medications. Dr. Hammad Khan, director of interventional psychiatry at Sutter Center for Psychiatry, emphasizes that SAINT aims to enhance brain connectivity and restore functionality in patients.
Treatment Process and Efficacy
SAINT treatment consists of five days of therapy, with patients receiving ten-minute bursts of magnetic pulses hourly for ten hours each day. This approach is significantly shorter than traditional transcranial magnetic stimulation (TMS), which typically requires around 35 sessions. According to Dr. Khan, approximately 70% to 80% of patients treated with SAINT experience improvement, outperforming both traditional TMS and electroconvulsive therapy (ECT).
Dr. Helen Kales, chair of psychiatry and behavioral sciences at UC Davis Health, anticipates that demand for SAINT will quickly exceed the capacity of both Sutter and UC Davis, which can accommodate only three new patients weekly. While Medicare covers the treatment, many commercial insurers do not, potentially leading to significant out-of-pocket costs for patients.
Technical Aspects of SAINT
The SAINT procedure utilizes advanced technology, including MRI scans to identify the precise treatment area in the dorsolateral prefrontal cortex. This mapping process ensures that the magnetic pulses are delivered accurately, enhancing the treatment's effectiveness. Patients remain awake during the procedure, often engaging in activities such as listening to music or reading, making it a non-invasive alternative to more traditional methods.
Criticism and Challenges
Despite the promising results, there are concerns regarding accessibility and insurance coverage. The limited capacity to treat patients and the high costs associated with SAINT may hinder its widespread adoption. Critics argue that without broader insurance acceptance, many individuals suffering from treatment-resistant depression may not benefit from this innovative therapy.
Verbatim Quotes
- “This is a way for us to take advantage of the way your brain is wired,” — Dr. Hammad Khan, Director of Interventional Psychiatry, Sutter Health
- “It’s something that’s delivered while you’re fully awake.” — Dr. Hammad Khan
- “It makes me giggle when my hand twitches.” — Brittany Chik, Registered Nurse, Sutter Center for Psychiatry
Conclusion
Sutter Health's introduction of SAINT therapy represents a significant advancement in the treatment of refractory depression, offering hope to patients who have not found relief through traditional methods. However, the challenges of accessibility and insurance coverage remain critical issues that need to be addressed to ensure that this innovative treatment can reach those in need.
